Yan Huang

机构：Chengdu Medical College, Sichuan University, Fudan University, West China Medical Center of Sichuan University, Chinese PLA General Hospital, West China Second University Hospital of Sichuan University, First Affiliated Hospital of Chengdu Medical College, Shenzhen Bao'an District People's Hospital, Shenzhen Children's Hospital, Zigong First People's Hospital, Hunan Agricultural University · ORCID：0000-0002-0816-1971

发表论文 76 篇 · 总被引 1033 次 · h-index 18

代表论文

• FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis (2022 · Frontiers in Genetics · 被引 30)
• BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials (2023 · Cancer Immunology Immunotherapy · 被引 14)
• Renal clear cell carcinoma-derived CXCL5 drives tumor-associated fibroblast formation and facilitates cancer progression (2023 · Pathology - Research and Practice · 被引 13)
• Mechanism of YAP1 in the senescence and degeneration of endplate chondrocytes induced by intermittent cyclic mechanical tension (2023 · Journal of Orthopaedic Surgery and Research · 被引 12)
• Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma (2022 · EJNMMI Research · 被引 8)
• Histological features suggestive of survival in patients with renal cell carcinoma and tumor thrombus: A single-center experience (2022 · Frontiers in Oncology · 被引 6)